New Therapeutic Vaccine Gives Hope Against an Aggressive Breast Cancer
2 days ago — THURSDAY, Nov. 14, 2024 (HealthDay News) -- An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests.
Hope for Patients with Aggressive Breast Cancer: Vaccine Trial …
17 hours ago — Following treatment, 14 of the 18 patients showed immune responses to the vaccine and, after three years, 16 patients remained cancer-free. While the early-stage trial was designed to evaluate the ...
Vaccine shows promise against aggressive breast cancer
In some of the vaccine clinical trials for breast cancer patients, personalized vaccines are being investigated in combination with immunotherapies called checkpoint inhibitors that boost the action of T cells. ... Julia covers medical news in genomics, cancer, cardiology, developmental biology, biochemistry & molecular biophysics, and gut ...
Cleveland Clinic Announces Updated Breast Cancer Vaccine …
Nov 8, 2024 — Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease. The study team found that the investigational vaccine was generally well tolerated and produced an immune response in most patients.
Breast cancer vaccine now in early clinical trials: What to know
Dec 11, 2023 — A new vaccine being studied in early clinical trials may hold the potential to help some women with breast cancer, a disease that affects one in every eight women in the United States, according to the Centers for Disease Control and Prevention.
Cleveland Clinic Announces Next Step in Preventive Breast Cancer ...
Feb 8, 2023 — Cleveland Clinic researchers have launched the next step in their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease. Funded by the U.S. Department of Defense, the new phase 1b study will enroll cancer-free individuals at high risk for developing breast cancer who have …
Pitt and UPMC Researchers Test First Vaccine Targeting Pre …
Jun 26, 2024 — On Thursday morning, June 20, 2024, Maria Kitay, 67, received her final dose of a new vaccine targeting pre-invasive breast cancer. She was the first patient to get the vaccine, developed by Pitt and UPMC researchers, as part of a clinical trial led by Olivera Finn (above), Distinguished Professor of immunology and of surgery in the School of ...
Breast cancer vaccine safely generates anti-tumor immunity
Oct 25, 2022 — An experimental vaccine against breast cancer safely generated a strong immune response to a key tumor protein, researchers from the University of Washington School of Medicine in Seattle report in a paper published by the journal JAMA Oncology. The findings suggest the vaccine may be able to treat different types of breast cancer.
Update on Phase 1 Trial of Preventive Breast Cancer Vaccine
Jan 4, 2024 — Current results from the phase 1 clinical trial of a novel vaccine under investigation at Cleveland Clinic were presented at the San Antonio Breast Cancer Symposium on December 6, 2023. The trial was created to determine the vaccine’s safety and dosage profiles in patients with early triple-negative breast cancer (TNBC) and is funded by the U ...
Breast cancer vaccine study begins with first patient - Medical …
Jun 21, 2024 — An innovative study of a breast cancer vaccine is officially underway, as University of Pittsburgh Medical Center announced on June 20 that the first participant had received her full course...
- Some results have been removed